Plasma insulin-like growth factor-i/somatomedin-c in acromegaly: Correlation with the degree of growth hormone hypersecretion

Journal of Clinical Endocrinology and Metabolism

Volumn 67, Issue 1, 1988, Pages 69-73

  Barkan, Ariel L ^a   Beitins, Inese Z ^a   Kelch, Robert P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN ANALOG;

ACROMEGALY; CLINICAL ARTICLE; GROWTH HORMONE RELEASE; HUMAN; SOMATOMEDIN C BLOOD LEVEL;

ACROMEGALY; ADOLESCENT; ADULT; AGED; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; OCTREOTIDE; SECRETORY RATE; SOMATOMEDINS; SOMATOSTATIN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023684610     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-67-1-69     Document Type: Article

References (30)

1. Clemmons DR, VanWyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE 1979 Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301:1138
2. Wass JAH, Clemmons DR, Underwood LE, Barrow I, Besser GM, VanWyk JJ 1982 Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly. Clin Endocrinol (Oxf) 17:369
3. Moses AC, Molitch ME, Sawin CT, Jackson IMD, Biller BJ, Furlanetto R, Reichlin S 1981 Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effects on serum levels of somatomedin C. J Clin Endocrinol Metab 53:752
4. Stonesifer LD, Jordan RM, Kohler PO 1981 Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response. J Clin Endocrinol Metab 53:931
5. Nortier JWR, Croughs RJM, Thijssen JHH, Schwarz F 1985 Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin C levels and clinical activity. Clin Endocrinol (Oxf)22:209
6. ccriptine treated acromegaly in relation to changes of somatomedin-C and clinical response. Acta Endocrinol (Copenh) 108:145
7. Oppizzi G, Petroncini MM, Dallabonzana D, Cozzi R, Verde G, Chiodini PG, Liuzzi A 1986 Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation. J Clin Endocrinol Metab 63:1348
8. Bercu BB, Shulman D, Root AW, Spiliotis BE 1986 Growth hormone (GH) provocative testing frequently does not reflect. endogenous GH secretion
9. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51
10. Barkan A, Kelch R, Beitins I, Growth hormone secretion in acromegaly: effects of somatostatin analogue SMS 201-995 (Sandoz). 68th Annual Meeting of The Endocrine Society, Anaheim CA, 1986, p 591 (Abstract)
11. Minuto F, Underwood LE, Grimaldi P, Furlanetto RW, VanWyk JJ, Giordano G 1981 Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. J Clin Endocrinol Metab 52:399
12. Rieu M, Girard F, Bricairt -T, Binoux M 1982 The importance of insulin-like growth factor omatomedin measurements in the diagnosis and surveillance o icromegaly. J Clin Endocrinol Metab 55:147
13. Schaison G, Couzinet B, Moatti N, Pertuiset B 1983 Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery. Clin Endocrinol (Oxf) 18:541
14. Rieu M, Kuhn JM, Bricaire H, Luton JP 1984 Evaluation of treated acromegalic patients with normal growth hormone levels during oral glucose load. Acta Endocrinol (Copenh) 107:1
15. Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ 1988 Treatment of acromegaly with the long-acting somatostatin analogue SMS 201-995. J Clin Endocrinol Metab 66:16
16. Furlanetto RW, Underwood LE, VanWyk JJ, D’Ercole AJ 1977 Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648
17. Baxter RC, Brown AS 1982 Purification of tracer for somatomedin-C radioimmunoassay by hydrophobic interaction chromatography. Clin Chem 28:485
18. Zar JH 1974 Biostatistical Analysis. Prentice Hall, Englewood Cliffs
19. Florini JR, Prinz PN, Vitiello MV, Hintz RL 1985 Somatomedin-C levels in healthy young and old men: relationship to peak and24-hour integrated levels of growth hormone. J Gerontol 40:2
20. Daughaday WH 1979 New criteria for evaluation of acromegaly. N Engl J Med 301:1175
21. Reichlin S 1982 Acromegaly. Med Grand Rounds 1:9
22. Christy NP 1982 Choosing the best treatment for acromegaly. JAMA 247:1320
23. Clemmons DR, Underwood LE, VanWyk JJ 1981 Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest 67:10
24. Scott CD, Martin JL, Baxter RC 1985 Rat hepatocyte insulin-likegrowth factor I and binding protein: effect of growth hormoneinvitroandin vivo.Endocrinology 116:1102
25. Hughes JP 1979 Identification and characterization of high and low affinity binding sites for growth hormone in rabbit liver. Endocrinology 105:414
26. Ranke MB, Stanley CA, Tenore A, Rodbard D, Bongiovanni AM, Parks JS 1976 Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. Endocrinology 99:1033
27. Fagin KD, Lackey SL, Reagan CR, DiGirolamo M 1978 Specific binding of growth hormone by rat adipocytes. Endocrinology 107:608
28. Gavin III JR, Saltman RJ, Tolejsen SE 1982 Growth hormone receptors in isolated rat adipocytes. Endocrinology 110:637
29. Lesniak MA, Roth J, Gordon P, Gavin III JR 1973 Human growth hormone radioreceptor assay using cultured human lymphocytes. Nature [New Biol] 241:20
30. Amit T, Barkey RJ, Guy J, Youdim MBH 1987 Specific binding sites for prolactin and growth hormone in the adult rabbit lung. Mol Cell Endocrinol 49:17